Longview Acquisition Corp II

Longview Acquisition Corp. II is a blank check company, which formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more entities. The company was founded on October 23, 2020 and is headquartered in New York, NY.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK--( BUSINESS WIRE )--On December 14, 2022, Longview Acquisition Corp. II (“Longview” or “the Company”) (NYSE: LGV.U, LGV and LGV WS) stockholders approved (i) an amendment to Longview's Amended and Restated Certificate of Incorporation (the “Charter”) (and the Charter, as amended, the “Second Amended and Restated Certificate of Incorporation”) and (ii) and an amendment to Longview's Investment Trust Management Agreement, dated March 18, 2021, by and between the Company and Continental Stock Transfer & Trust Company, a New York limited purpose trust company (“Continental”), as trustee (the “Amendment to the Investment Trust Management Agreement”) to allow Longview to (i) change the date by which the Company must consummate a business combination from March 23, 2023 to September 23, 2023 or such earlier date as is determined by the Company's board of directors (the “Board”) in its sole discretion and publicly announced by the Company and (ii) change the date on which Continental must commence liquidation of the trust account from (A) the earlier of the Company's completion of an initial business combination and March 23, 2023 to (B) the earliest of (i) the Company's completion of an initial business combination, (ii) September 23, 2023 or such earlier date as is determined by the Board in its sole discretion and publicly announced by the Company.

Longview Acquisition Corp. II Amends Charter and Trust Agreement to Redeem Public Shares Before Year-End and Announces December 14, 2022 as Amended Termination Date

HeartFlow Holding Inc and a special purpose acquisition company, Longview Acquisition Corp II (NYSE: LGV), have called off merger plans that would have taken the cardiac test company public. HeartFlow described the move as a mutual decision a "result of current unfavorable market conditions.

HeartFlow, Longview Acquisition SPAC Deal Called Off

REDWOOD CITY, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) -- HeartFlow Holding, Inc. (“HeartFlow”), the leader in revolutionizing precision heart care, today announced that it and Longview Acquisition Corporation II (NYSE: LGV), a special purpose acquisition company sponsored by affiliates of Glenview Capital Management, LLC, have mutually agreed to terminate their previously announced business combination agreement, effective immediately, as a result of current unfavorable market conditions.

HeartFlow Announces Mutual Termination of Business Combination Agreement

Heartflow Holding Inc (NYSE: HFLO) aims to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a SPAC merger with Longview Acquisition Corp II (NYSE: LGV).  Once the deal, valued at an enterprise value of about $2.4 billion, is complete, the resulting public company will operate under HeartFlow's banner with the NYSE ticker HFLO.

Heartflow Charts NYSE Debut IPO Via $2.4B SPAC Deal

REDWOOD CITY, Calif. & NEW YORK--(BUSINESS WIRE)--HeartFlow Holding, Inc. (“HeartFlow”, or the “Company”), the leader in revolutionizing precision heart care, and Longview Acquisition Corp. II (NYSE: LGV) (“Longview”), a special purpose acquisition company sponsored by affiliates of Glenview Capital Management, LLC (“Glenview”), announced today that they have entered into a definitive business combination agreement that will support HeartFlow's vision of revolutionizing precision heart care. Up

HeartFlow, the Leader in Precision Heart Care, Announces Merger with Longview Acquisition Corp. II to Become a Publicly Traded Company

News for Longview Acquisition Corp II Stock (LGV)